Home > Financial Ratios > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Core EBITDA Growth

    Back to All Ratios
TATVA CHINTAN PHARMA CHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results

TATVA CHINTAN PHARMA CHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 14.10-43.4063.5226.8663.71

What is the latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM ?

The latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM is 14.10 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202414.10
Mar2023-43.40
Mar202263.52
Mar202126.86
Mar202063.71

How is Core EBITDA Growth of TATVA CHINTAN PHARMA CHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 14.1
Positive
Mar2023 -43.4
Negative
Mar2022 63.52
136.49
Mar2021 26.86
-57.84
Mar2020 63.71 -

Other Financial Ratios of TATVA CHINTAN PHARMA CHEM


Compare Core EBITDA Growth ratio of peers of TATVA CHINTAN PHARMA CHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM ₹1,889.0 Cr -4% -16.5% -45.2% Stock Analytics
PIDILITE INDUSTRIES ₹149,420.0 Cr -1.5% -6.8% 22.1% Stock Analytics
SOLAR INDUSTRIES INDIA ₹90,193.2 Cr 2.7% -11.7% 45.7% Stock Analytics
SRF ₹63,501.6 Cr -2.7% -5.9% -6.6% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹42,112.1 Cr -5.4% -20.2% 40.1% Stock Analytics
DEEPAK NITRITE ₹35,738.4 Cr 4.8% -5.7% 24.4% Stock Analytics


TATVA CHINTAN PHARMA CHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

-4%

-16.5%

-45.2%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses